Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELLAR: CHOP-R +/- Acalabrutinib in Richter's Syndrome
NCT03899337Phase 2Active, not recruiting
- Sponsor
- University of Birmingham
- Start
- Jul 2019
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of acalabrutinib tablet (Variant 1) in Richter's syndrome (RS), sponsored by University of Birmingham. Started Jul 2019; status: active, not recruiting.
02
Drugs
acalabrutinib tablet (Variant 1)
03
Conditions
Richter's syndrome (RS)
Beyond the preview
Go deeper on NCT03899337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899337.